ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies.
Ramon Alfredo C. Siochi, PhD, DABR, FAAPM is the Associate Chair and the Director of Medical Physics of the Department of Radiation Oncology at West Virginia University Medicine was selected to give an oral presentation: Improving Interconnectivity and Intra operability in radiation oncology; IHE-RO Initiative.
Integrating Healthcare Enterprise - Radiation Oncology (IHE-RO) is an initiative that helps to ensure a safe, efficient radiation oncology practice by improving system to system connections. With technology at the core of delivering care in radiation oncology, it is imperative that patient safety is not compromised. Integrating Healthcare Enterprise - Radiation Oncology (IHE-RO) is an initiative that helps to ensure a safe, efficient radiation oncology practice by improving system to system connections.
WVU faculty and residents presented the following posters:
Influence of dexamethasone premedication on acute lung toxicity in lung SBRT. F Alite, MP Shaikh, MJ Greenberg, D Christie, A Rostock, U Malik, A Mahadevan
Patterns of relapse after salvage autologous hematopoietic cell transplantation for Hodgkin’s lymphoma: should site of relapse relative to initially involved sites be used to guide indications for peritransplant radiation therapy. JC Farris, A Ritter, MD Craig, N Shah, L Veltri, A Kanate, K Ross, J A Vargo
Radiation associated hypertension in patients undergoing prostate irradiation. Farrugia M, Bianco C, Sambamoorthi U, Mattes M
Tumor cavity recurrence after stereotactic radiosurgery of surgically resected brain metastases: Implication of deviation from contouring guidelines. D McDermott, J Hack, C Cifarelli, JA Vargo
Predictors of local control and symptomatic pneumonitis after lung SBRT. S Parker, LM Schmidt, S Wen, MD Mattes
The lack of consensus of international contouring guidelines for the dorsal border of the chest wall clinical target volume: What is the impact on organs at risk and relationships in the modern era? P Pifer, R Bice, GM Jacobson, K Lupinacci, S Beriwal, H Hazard, JA Vargo
W est Virginia University’s Cancer Institute is well-known for its treatment and innovation. Leading the institute is Dr. Richard Goldberg, who has not only established himself as a transformative leader but also a potent researcher and educator. A native of upstate New York, the renowned gastrointestinal cancer expert came to Morgantown about two years ago. Goldberg previously worked at The Ohio State University’s Wexner Medical Center, where he served as the Klotz Family Professor of Cancer Research, the physician‐in‐ chief of the James Cancer Hospital, the associate director of the Ohio State Comprehensive Cancer Center and the acting division director of the Division of Medical Oncology. Before that, he also worked at the University of North Carolina and the Mayo Clinic. Goldberg is one of many world-class physicians recruited by WVU Medicine during the past few years, whose research has resulted in more than 300 peer-reviewed publications, including those in the New England Journal of Medicine, the Journal of the American Medical Association and the Journal of Clinical Oncology
The WVU Cancer Institute is among six organizations to receive an inaugural Medline Breast Cancer Awareness grant, which is awarded to organizations to further the mission to eradicate breast cancer and provide counseling. The grant drives awareness around prevention and early detection by providing support to organizations that provide direct patient care.
Researchers across campus are taking a One WVU approach to solving important problems and saving lives. At its core, an experimental therapeutics platform that integrates multiple disciplines from chemistry and biology to the health sciences and cancer institute.